Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. AMIX
AMIX logo

AMIX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AMIX News

Autonomix Medical Releases Latest CEO Corner Segment

Feb 25 2026Newsfilter

Autonomix Medical to Present Long-Term Clinical Data at SSO 2026

Feb 19 2026Newsfilter

OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%

Dec 30 2025Benzinga

FONAR Corporation Confirms Take-Private Deal, Shares Surge 28%

Dec 30 2025Benzinga

Autonomix Secures European Patent, Expanding Cardiac Treatment Market

Dec 30 2025Newsfilter

Autonomix Medical Advances Nerve-Targeted Treatment Technology

Nov 26 2025Newsfilter

Autonomix Medical Advances Nerve-Targeted Treatment Technology

Nov 26 2025Globenewswire

Gorilla Technology Shares Rise Approximately 14%; Check Out 20 Stocks Making Moves in Premarket Trading

Nov 18 2025Benzinga

Nasdaq Rises as New York Manufacturing Activity Soars in November

Nov 17 2025Benzinga

Dow Drops More Than 150 Points; Aramark Stock Declines Following Q4 Earnings Report

Nov 17 2025Benzinga

Autonomix Medical, Inc. Receives U.S. Patent for Platform Technology Facilitating Precision Nerve-Targeted Treatments in Cardiology

Oct 09 2025Newsfilter

Autonomix Medical, Inc. Unveils Upcoming CEO Corner Segment

Oct 02 2025Newsfilter

Autonomix Medical, Inc. Shows Long-Term Pain Relief, Improved Quality of Life, and Complete Opioid-Free Outcomes in Extended Post Hoc Analysis of PoC 1 Study

Sep 03 2025Newsfilter

Autonomix Medical, Inc. Receives New European Patent for Innovative Catheter-Based Technology

Aug 20 2025Newsfilter

Autonomix Medical, Inc. to Join Virtual Investor Webinar Organized by Ladenburg Thalmann & Co. Inc.

Aug 18 2025Newsfilter

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15 2025Newsfilter